1,030 filings
Page 33 of 52
S-8
xvz54bo7hv rz5
6 Jun 16
Registration of securities for employees
12:00am
8-K
9pguyi5cxnxrty
6 Jun 16
ASCO Oral Presentation Demonstrates Trovagene’s Liquid Biopsy Urine Test Detects EGFR T790M Mutations in Patients with Non-Small Cell Lung Cancer
12:00am
8-K
hzvrqux
19 May 16
Other Events
12:00am
8-K
wa96xd9jy40wnv32ta0
18 May 16
Departure of Directors or Certain Officers
12:00am
8-K
eywh v1nopib
17 May 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
6xvs 9r0q
13 May 16
92.9% of metastatic pancreatic cancer patients determined to be KRAS positive using Trovagene’s Precision Cancer Monitoring assay
12:00am
8-K
c021moc3k
10 May 16
Trovagene Announces First Quarter 2016 Financial Results
12:00am
4
zvfse d7q
4 May 16
Trovagene / Mark Erlander ownership change
12:00am
3
6p24y rc7
27 Apr 16
Trovagene / WILLIAM J WELCH ownership change
12:00am
8-K
ghzfxvyt4cd7irzum115
27 Apr 16
Departure of Directors or Certain Officers
12:00am
8-K
o7npvps
25 Apr 16
Trovagene Appoints Bill Welch as Chief Executive Officer
12:00am
4
9jbi3usw ufa
22 Apr 16
Trovagene / STEVE ZANIBONI ownership change
12:00am
8-K
w6v3xr4oxf1pnw
15 Apr 16
Other Events
12:00am
8-K
xn8 51lbn
11 Apr 16
Trovagene Enters Into Preferred Provider Agreement with Stratose PPO Network
12:00am
8-K
27gqv pju98hcljggs
7 Apr 16
Clinical Data Featuring Trovagene's Precision Cancer Monitoring Platform to be Presented at the Molecular DX Europe Conference
12:00am
SC 13D
ygnv vjs5ypsz35vj4
5 Apr 16
Trovagene, Inc.
12:00am
DEFA14A
ldr6gn
31 Mar 16
Additional proxy soliciting materials
12:00am